Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT06592144Phase 4Active, not recruiting
A Phase 4 trial of testosterone cypionate in Intensive Care Unit Acquired Weakness (ICUAW), Weaning failure. Started Sep 2024; status: active, not recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT06592144.